close

Enter

Log in using OpenID

Prescription Narcotics Market Global Trends, Market Share, Industry Size, Growth, Opportunities, and Market Forecast 2019 to 2026

embed
Prescription narcotics are a type of drug that has the potential to be addictive. Because of their addictive potential, this type of drug should only be used according to a doctor’s specific prescription. These narcotics are also used as pain killer
Prescription Narcotics Market Global Trends, Market Share, Industry Size, Growth,
Opportunities, and Market Forecast 2019 to 2026
Prescription narcotics are a type of drug that has the potential to be addictive.
Because of their addictive potential, this type of drug should only be used according
to a doctor’s specific prescription. These narcotics are also used as pain killers to
relieve pain from the body and this narcotic work in the body by binding themselves
to pain receptors in the nervous system so that the pain signals are blocked. As a
result, this type of drug is sometimes prescribed to temporarily treat severe pain that
doesn’t respond to other forms of pain relievers.
Increasing demand of opioids in clinical practice for treating chronic pain conditions
is fuelling the growth of the market. Along with increasing demand, rising prevalence
of chronic pain is expected to boost the utilization of narcotics in effective chronic
pain treatment. According to CDC, 11% of adult population in the US is experiencing
some form of chronic pain. Further, changing regulatory conditions to encourage the
utilization of narcotics in better management of pain led to potential growth of the
market. Further, opioids are only available effective therapy for severe pains when
compared to alternatives treatment options. All these factors led to potential growth
of the market during forecast period.
Global market is dominated by North America market due to supportive regulatory
environment. It is expected to remain dominant throughout forecast period and it
witnessed a large number of manufacturers. It is followed by Europe market due to
high adoption of opioids for effective management of pain. Asia Pacific and Latin
America is fast growing region due to increasing adoption of opioids in clinical
practice. Further, high prevalence of chronic pain in these regions is expected fuel
the growth of the market. Rest of World is also fast-growing region due to increasing
adoption among end-user segment led to potential growth of the market.
Prescription Narcotics market players include Pfizer Inc, Novartis AG, J&J, Merck Co.
& Inc, Roche Holding, Bayer AG, AstraZeneca, Sanofi Plc and others
Request a Sample Report @ https://www.futurewiseresearch.com/requestsample.aspx?id=214&page=requestsample
Prescription Narcotics Market Segmentation
By Indication
+ Cancer Pain
+ Trauma
+ Analgesics
+ Others
By Sales Channel
+ Retail Pharmacies
+ Institutional Distribution
By Region
+ North America
+ Latin America
+ Europe
+ Asia Pacific
+ Rest of the World
Purchase a Copy of this Premium Research Report & Ask For Discount:
https://www.futurewiseresearch.com/requestsample.aspx?id=214&page=askfordiscount
Competitive Landscape:
• Tier 1 players- established companies in the market with a major market share
• Tier 2 players
• Emerging players which are growing rapidly
• New Entrants
FutureWise Key Takeaways
• Growth prospects
• SWOT analysis
• Key trends
• Key data-points affecting market growth
Objectives of the Study:
• To provide with an exhaustive analysis on the global Prescription Narcotics
Market by Indication, by Sales Channel, and by Region
• To cater comprehensive information on factors impacting market growth (drivers,
restraints, opportunities, and industry-specific restraints)
• To evaluate and forecast micro-markets and the overall market
• To predict the market size, in key regions (along with countries)—North America,
Europe, Asia Pacific, Latin America, and the Middle East
• To record evaluate and competitive landscape mapping- product launches,
technological advancements, mergers and expansions
• Profiling of companies to evaluate their market shares, strategies, financials and
core competencies
Table of Contents
1. Introduction
1.1.1.1. Scope and Objective
1.1.1.2. Assumptions and Acronyms
1.1.1.3. Forecast Factors
1.1.1.4. Research Methodology
2. Executive Summary
2.1.1.1. Industry Cluster Analysis
2.1.1.2. Competition Matrix
2.1.1.3. Strategies Recommendations
3. Market Definition
3.1.1.1. Report Scope (Inclusions & Exclusions)
3.1.1.2. Market Segmentation
4. Global Prescription Narcotics Market Overview
4.1.1.1. Global Prescription Narcotics Market Revenue (USD Mn)
5. Key Inclusions
5.1.1.1. Porter’s Five Force analysis
5.1.1.2. Market Dynamics
5.1.1.3. Industry Trends
5.1.1.4. Regulatory Guidelines
5.1.1.5. Opportunities in Prescription Narcotics
6. Competition Dynamics
6.1.1.1. Company Share Analysis (2018)
6.1.1.2. Top 10 Product Pricing by Region
7. Global Prescription Narcotics Market Revenue (USD Mn), 2018-2026 by
Indication
7.1.1.1. Key Market Findings
7.1.1.2. Long Term ROI Segments
7.1.1.3. Revenue Opportunity Influencing Factors
7.1.1.4. Market Revenue (USD Mn) Assessment and Forecast by
Indication, 2018-2026
7.1.1.4.1.1.
Cancer Pain
7.1.1.4.1.2.
Trauma
7.1.1.4.1.3.
Analgesics
7.1.1.4.1.4.
Others
8. Global Prescription Narcotics Market Revenue (USD Mn), 2018-2026 by Sales
Channel
8.1.1.1. Key Market Findings
8.1.1.2. Long Term ROI Segments
8.1.1.3. Revenue Opportunity Influencing Factors
8.1.1.4. Market Revenue (USD Mn) Assessment and Forecast by Sales
Channel, 2018-2026
8.1.1.4.1.1.
Retail Pharmacies
8.1.1.4.1.2.
Institutional Distribution
9. Global Prescription Narcotics Market Revenue (USD Mn), 2018-2026 by Region
9.1.1.1. Key Market Findings
9.1.1.2. Long Term ROI Segments
9.1.1.3. Revenue Opportunity Influencing Factors
9.1.1.4. Market Revenue (USD Mn) Assessment and Forecast by
Region,2026
9.1.1.4.1.1.
North America
9.1.1.4.1.2.
Latin America
9.1.1.4.1.3.
Europe
9.1.1.4.1.4.
Asia Pacific
9.1.1.4.1.5.
Rest of world
10. North America Prescription Narcotics Market Revenue (US$ Mn), 2018-2026
10.1.1.1. Key Market Findings
10.1.1.2. Long Term ROI Segments
10.1.1.3. Revenue Opportunity Influencing Factors
10.1.1.4. Market Revenue (USD Mn) Assessment and Forecast by Country,
2018-2026
10.1.1.4.1.1.
US
10.1.1.4.1.2.
Canada
10.1.1.5. Market Revenue (USD Mn) Assessment and Forecast by
Indication, 2018-2026
10.1.1.5.1.1.
Cancer Pain
10.1.1.5.1.2.
Trauma
10.1.1.5.1.3.
Analgesics
10.1.1.5.1.4.
Others
10.1.1.6. Market Revenue (USD Mn) Assessment and Forecast by Sales
Channel, 2018-2026
10.1.1.6.1.1.
Retail Pharmacies
10.1.1.6.1.2.
Institutional Distribution
11. Latin America Prescription Narcotics Market Revenue (US$ Mn), 2018-2026
11.1.1.1. Key Market Findings
11.1.1.2. Long Term ROI Segments
11.1.1.3. Revenue Opportunity Influencing Factors
11.1.1.4. Market Revenue (USD Mn) Assessment and Forecast by Country,
2018-2026
11.1.1.4.1.1.
Brazil
11.1.1.4.1.2.
Mexico
11.1.1.4.1.3.
Argentina
11.1.1.4.1.4.
Rest of Latin America
11.1.1.5. Market Revenue (USD Mn) Assessment and Forecast by
Indication, 2018-2026
11.1.1.5.1.1.
Cancer Pain
11.1.1.5.1.2.
Trauma
11.1.1.5.1.3.
Analgesics
11.1.1.5.1.4.
Others
11.1.1.6. Market Revenue (USD Mn) Assessment and Forecast by Sales
Channel, 2018-2026
11.1.1.6.1.1.
Retail Pharmacies
11.1.1.6.1.1.1.
Institutional Distribution
12. Europe America Prescription Narcotics Market Revenue (US$ Mn), 2018-2026
12.1.1.1. Key Market Findings
12.1.1.2. Long Term ROI Segments
12.1.1.3. Revenue Opportunity Influencing Factors
12.1.1.4. Market Revenue (USD Mn) Assessment and Forecast by Country,
2018-2026
12.1.1.4.1.1.
Germany
12.1.1.4.1.2.
France
12.1.1.4.1.3.
Spain
12.1.1.4.1.4.
UK
12.1.1.4.1.5.
Russia
12.1.1.4.1.6.
Poland
12.1.1.4.1.7.
Rest of Europe
12.1.1.5. Market Revenue (USD Mn) Assessment and Forecast by
Indication, 2018-2026
12.1.1.5.1.1.
Cancer Pain
12.1.1.5.1.2.
Trauma
12.1.1.5.1.3.
Analgesics
12.1.1.5.1.4.
Others
12.1.1.6. Market Revenue (USD Mn) Assessment and Forecast by Sales
Channel, 2018-2026
12.1.1.6.1.1.
Retail Pharmacies
12.1.1.6.1.2.
Institutional Distribution
13. Asia Pacific America Prescription Narcotics Market Revenue (US$ Mn), 20182026
13.1.1.1. Key Market Findings
13.1.1.2. Long Term ROI Segments
13.1.1.3. Revenue Opportunity Influencing Factors
13.1.1.4. Market Revenue (USD Mn) Assessment and Forecast by Country,
2018-2026
13.1.1.4.1.1.
Emerging Asia
13.1.1.4.1.1.1.1. China
13.1.1.4.1.1.1.2. India
13.1.1.4.1.1.1.3. ASEAN-5
13.1.1.4.1.1.1.4. Rest of Emerging Asia
13.1.1.4.1.2.
Japan
13.1.1.5. Market Revenue (USD Mn) Assessment and Forecast by
Indication, 2018-2026
13.1.1.5.1.1.
Cancer Pain
13.1.1.5.1.2.
Trauma
13.1.1.5.1.3.
Analgesics
13.1.1.5.1.4.
Others
13.1.1.6. Market Revenue (USD Mn) Assessment and Forecast by Sales
Channel, 2018-2026
13.1.1.6.1.1.
Retail Pharmacies
13.1.1.6.1.2.
Institutional Distribution
14. Rest of World America Prescription Narcotics Market Revenue (US$ Mn), 20182026
14.1.1.1. Key Market Findings
14.1.1.2. Long Term ROI Segments
14.1.1.3. Revenue Opportunity Influencing Factors
14.1.1.4. Market Revenue (USD Mn) Assessment and Forecast by Country,
2018-2026
14.1.1.4.1.1.
Middle East
14.1.1.4.1.2.
South Africa
14.1.1.4.1.3.
North Africa
14.1.1.4.1.4.
Rest of World
14.1.1.5. Market Revenue (USD Mn) Assessment and Forecast by
Indication, 2018-2026
14.1.1.5.1.1.
Cancer Pain
14.1.1.5.1.2.
Trauma
14.1.1.5.1.3.
Analgesics
14.1.1.5.1.4.
Others
14.1.1.6. Market Revenue (USD Mn) Assessment and Forecast by Sales
Channel, 2018-2026
14.1.1.6.1.1.
Retail Pharmacies
14.1.1.6.1.1.1.
Institutional Distribution
15. Company Profiles
15.1.1.1. Competition Landscape
15.1.1.2. Global Company Share (USD Mn) Overview, 2018
15.1.1.3. Company Profiles
15.1.1.3.1.1.
Pfizer Inc
15.1.1.3.1.1.1.1. Corporate Overview
15.1.1.3.1.1.1.2. Financial Performance
15.1.1.3.1.1.1.3. Peer Comparison & 3C marketing equation
15.1.1.3.1.1.1.4. Company Strategy & Channel Management
15.1.1.3.1.2.
Novartis AG
15.1.1.3.1.2.1.1. Corporate Overview
15.1.1.3.1.2.1.2. Financial Performance
15.1.1.3.1.2.1.3. Peer Comparison & 3C marketing equation
15.1.1.3.1.2.1.4. Company Strategy & Channel Management
15.1.1.3.1.3.
J&J
15.1.1.3.1.3.1.1. Corporate Overview
15.1.1.3.1.3.1.2. Financial Performance
15.1.1.3.1.3.1.3. Peer Comparison & 3C marketing equation
15.1.1.3.1.3.1.4. Company Strategy & Channel Management
15.1.1.3.1.4.
Merck Co. & Inc
15.1.1.3.1.4.1.1. Corporate Overview
15.1.1.3.1.4.1.2. Financial Performance
15.1.1.3.1.4.1.3. Peer Comparison & 3C marketing equation
15.1.1.3.1.4.1.4. Company Strategy & Channel Management
15.1.1.3.1.5.
Roche Holding
15.1.1.3.1.5.1.1. Corporate Overview
15.1.1.3.1.5.1.2. Financial Performance
15.1.1.3.1.5.1.3. Peer Comparison & 3C marketing equation
15.1.1.3.1.5.1.4. Company Strategy & Channel Management
15.1.1.3.1.6.
Bayer AG
15.1.1.3.1.6.1.1. Corporate Overview
15.1.1.3.1.6.1.2. Financial Performance
15.1.1.3.1.6.1.3. Peer Comparison & 3C marketing equation
15.1.1.3.1.6.1.4. Company Strategy & Channel Management
15.1.1.3.1.7.
AstraZeneca
15.1.1.3.1.7.1.1. Corporate Overview
15.1.1.3.1.7.1.2. Financial Performance
15.1.1.3.1.7.1.3. Peer Comparison & 3C marketing equation
15.1.1.3.1.7.1.4. Company Strategy & Channel Management
15.1.1.3.1.8.
Sanofi Plc
15.1.1.3.1.8.1.1. Corporate Overview
15.1.1.3.1.8.1.2. Financial Performance
15.1.1.3.1.8.1.3. Peer Comparison & 3C marketing equation
15.1.1.3.1.8.1.4. Company Strategy & Channel Management
16. Research Sources & Primary Verbatim
Inquire further details about this report at: [email protected]
About FutureWise Research:
We specialise in high-growth niche markets, assuring flexibility, agility and
customised solutions for our clients. Through in-depth market insights and
consultancy, we present our clients with the tools they need to be at the forefront of
their industry – a position secured for far more than the near future.
Contact Us:
Company Name: FutureWise Research
Contact Person: Vinay Thaploo
Email: [email protected]
Phone: +44 141 628 9353 / +1 970 279 4295
City: Leeds
Country: United Kingdom
Website: www.futurewiseresearch.com
1/--pages
Report inappropriate content